Should I buy Cognex (CGNX) stock or is it too late?

Cognex · Information Technology · price $60

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Cantor Fitzgerald — 88% of its targets hit on this sector (8 calls tested). It aims for $84 (+40 %), call made on August 8, 2026, maturing on August 8, 2027 (67 d ago).

The 5 reliable analysts $74+23 %

The 5 other firms $75+25 %

How to read it: the 5 reliable firms are not filtered by optimism — 5 aim above the price, 0 below, hence their $74 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Cognex

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
Needham	47 %	+8.4 %	19	$80 +33%
Goldman Sachs	36 %	-31.3 %	11	$80 +33%
Raymond James	64 %	+7.0 %	11	—
CLSA	60 %	+6.4 %	5	—
Morgan Stanley	64 %	-1.6 %	11	—

In short — Should you invest in Cognex? Is it too late, still worth it? Analysts are fairly positive (55% buy, median target $75, i.e. +25%), and the most reliable on CGNX targets even higher. But the stock is volatile, it pays virtually no dividend. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

Median price target $75, i.e. +25% from the current price ($60).
The most reliable firm on CGNX, Stephens & Co. (100% hit rate, 3 scored calls), targets $75 (call made on May 7, 2026, maturing on May 7, 2027) (+25%) in its most recent call.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 11 ratings, 5 are neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.
Volatile stock: sharp swings — including steep drops — are part of its profile.
Negligible dividend (0.5% yield): your return depends mostly on price appreciation.

The analyst consensus on CGNX

Median target $75 (+25%) · 11 ratings · Buy consensus

Strong Buy00%

Buy655%

Hold545%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Cognex now?

We won't decide for you. The facts: 55% of analysts rate it a buy, median target $75 (+25%), and Stephens & Co. (most reliable on CGNX, 100%) targets $75. Weigh that against valuation and volatility. This is not personalized advice.

Is it too late to invest in Cognex?

Not according to analysts: the median target ($75) is still +25% above the current price ($60) (most reliable on CGNX: Stephens & Co., 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Cognex still worth investing in?

It depends on the gap between the price ($60) and its estimated value: analysts target $75 on median (+25%), with 55% buys (most reliable on CGNX: Stephens & Co., 100%). Cross-check with their real reliability on CGNX and the cautions above. Information, not advice.

What's the main risk in buying CGNX?

The consensus is not unanimous: of 11 ratings, 5 are neutral.

→ Go deeper: the full Cognex profile (consensus, analyst reliability, price target, performance).